A combination of immunoadjuvant nanocomplexes and dendritic cell vaccines in the presence of immune checkpoint blockade for effective cancer immunotherapy

Cell Mol Immunol. 2021 Jun;18(6):1599-1601. doi: 10.1038/s41423-021-00666-z. Epub 2021 Mar 29.

Manh-Cuong Vo^#^{1

2

3}, Seo-Yeon Ahn^#^{2

3}, Tan-Huy Chu^#², Saji Uthaman⁴, Shammer Pillarisetti⁵, Tung Nguyen Thanh Uong⁶, Thangaraj Jaya Lakshmi², Mihee Kim³, Ga-Young Song³, Sung-Hoon Jung^{2

3}, Deok-Hwan Yang³, Jae-Sook Ahn³, Hyeoung-Joon Kim³, In-Kyu Park⁷, Je-Jung Lee^{8

9}

¹ Institute of Research and Development, Duy Tan University, Danang, Vietnam.
² Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital, Hwasun, Jeollanamdo, Republic of Korea.
³ Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea.
⁴ Department of Polymer Science and Engineering, Chungnam National University, Daejeon, Republic of Korea.
⁵ Department of Biomedical Science, Chonnam National University Medical School, Gwangju, Republic of Korea.
⁶ Department of Radiation Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, South Korea.
⁷ Department of Biomedical Science, Chonnam National University Medical School, Gwangju, Republic of Korea. pik96@jnu.ac.kr.
⁸ Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital, Hwasun, Jeollanamdo, Republic of Korea. drjejung@chonnam.ac.kr.
⁹ Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea. drjejung@chonnam.ac.kr.

^# Contributed equally.

No abstract available

Publication types